STOCK TITAN

National Vision Financials

EYE
Source SEC Filings (10-K/10-Q) Data as of Apr 4, 2026 Currency USD FYE January

This page shows National Vision (EYE) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI EYE FY2026

National Vision’s business still converts sales into cash, but self-funded deleveraging has left little short-term slack.

With gross margin essentially unchanged at 58.1% in FY2024 and 58.8% in FY2026, the return to positive operating profit points to better overhead absorption, not a reinvention of the product economics. That matters because operating cash flow was $146.3M against just $29.6M of net income in FY2026, confirming that reported earnings understate the cash the business produced.

The balance sheet is moving in a deleveraging direction: long-term debt fell from $437.7M in FY2023 to $223.2M in FY2026, and total liabilities also came down. But the cash cushion also shrank, leaving just $38.7M of cash and a current ratio of 0.5x, so near-term liquidity looks tight even though leverage eased.

Even during the FY2023-FY2024 loss period, the company kept free cash flow positive, which suggests noncash charges and tighter working capital offset weak margins rather than the business needing fresh capital to operate. FY2026 free cash flow of $73.5M after $72.8M of capital spending shows reinvestment needs are meaningful, but not so large that they overwhelm cash generation.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 38 / 100
Financial Health Score 38/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of National Vision's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
40

National Vision has an operating margin of 3.0%, meaning the company retains $3 of operating profit per $100 of revenue. This results in a moderate score of 40/100, indicating healthy but not exceptional operating efficiency. This is up from -0.6% the prior year.

Growth
56

National Vision's revenue grew 9.0% year-over-year to $2.0B, a solid pace of expansion. This earns a growth score of 56/100.

Leverage
46

National Vision has a moderate D/E ratio of 0.24. This balance of debt and equity financing earns a leverage score of 46/100.

Liquidity
7

National Vision's current ratio of 0.62 is below the typical benchmark, resulting in a score of 7/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
40

National Vision has a free cash flow margin of 3.7%, earning a moderate score of 40/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
39

National Vision's ROE of 3.3% shows moderate profitability relative to equity, earning a score of 39/100. This is up from -3.5% the prior year.

Altman Z-Score Grey Zone
2.12

National Vision scores 2.12, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Strong
8/9

National Vision passes 8 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed
4.94x

For every $1 of reported earnings, National Vision generates $4.94 in operating cash flow ($146.3M OCF vs $29.6M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$2.0B
YoY+9.0%
5Y CAGR+3.0%
10Y CAGR+6.5%

National Vision generated $2.0B in revenue in fiscal year 2026. This represents an increase of 9.0% from the prior year.

EBITDA
$150.0M
YoY+85.2%
5Y CAGR-3.4%
10Y CAGR+5.4%

National Vision's EBITDA was $150.0M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 85.2% from the prior year.

Net Income
$29.6M
YoY+203.9%
5Y CAGR-4.0%
10Y CAGR+23.4%

National Vision reported $29.6M in net income in fiscal year 2026. This represents an increase of 203.9% from the prior year.

EPS (Diluted)
$0.37
YoY+202.8%
5Y CAGR-3.4%
10Y CAGR+20.0%

National Vision earned $0.37 per diluted share (EPS) in fiscal year 2026. This represents an increase of 202.8% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$73.5M
YoY+92.6%
5Y CAGR-14.2%
10Y CAGR+28.5%

National Vision generated $73.5M in free cash flow in fiscal year 2026, representing cash available after capex. This represents an increase of 92.6% from the prior year.

Cash & Debt
$67.9M
YoY-8.2%
5Y CAGR-31.6%
10Y CAGR+29.9%

National Vision held $67.9M in cash against $223.2M in long-term debt as of fiscal year 2026.

Dividends Per Share
N/A
Shares Outstanding
80M
YoY+1.7%
5Y CAGR-0.3%
10Y CAGR+3.6%

National Vision had 80M shares outstanding in fiscal year 2026. This represents an increase of 1.7% from the prior year.

Margins & Returns

Gross Margin
58.8%
YoY+0.7pp
5Y CAGR+4.7pp
10Y CAGR+5.0pp

National Vision's gross margin was 58.8% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is up 0.7 percentage points from the prior year.

Operating Margin
3.0%
YoY+3.5pp
5Y CAGR-2.1pp
10Y CAGR-1.2pp

National Vision's operating margin was 3.0% in fiscal year 2026, reflecting core business profitability. This is up 3.5 percentage points from the prior year.

Net Margin
1.5%
YoY+3.0pp
5Y CAGR-0.6pp
10Y CAGR+1.1pp

National Vision's net profit margin was 1.5% in fiscal year 2026, showing the share of revenue converted to profit. This is up 3.0 percentage points from the prior year.

Return on Equity
3.3%
YoY+6.8pp
5Y CAGR-0.8pp
10Y CAGR+2.4pp

National Vision's ROE was 3.3% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is up 6.8 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
$3.2M
YoY+3.7%
5Y CAGR+36.0%

National Vision spent $3.2M on share buybacks in fiscal year 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 3.7% from the prior year.

Capital Expenditures
$72.8M
YoY-23.7%
5Y CAGR-1.1%
10Y CAGR-0.6%

National Vision invested $72.8M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents a decrease of 23.7% from the prior year.

EYE Income Statement

Metric Q1'27 Q4'26 Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25
Revenue $543.9M+8.0% $503.4M+3.3% $487.3M+0.2% $486.4M-4.7% $510.3M+16.7% $437.3M-3.2% $451.5M0.0% $451.7M
Cost of Revenue $219.1M+4.0% $210.7M+3.7% $203.2M+1.4% $200.4M-2.3% $205.2M+10.9% $185.0M-2.6% $189.9M-1.9% $193.6M
Gross Profit $324.7M+10.9% $292.7M+3.0% $284.1M-0.7% $286.1M-6.3% $305.1M+21.0% $252.3M-3.6% $261.6M+1.3% $258.2M
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $256.1M-2.0% $261.2M+3.5% $252.3M+2.1% $247.2M-3.3% $255.5M N/A $234.0M+1.1% $231.4M
Operating Income $45.2M+581.8% $6.6M-30.9% $9.6M-41.6% $16.4M-37.1% $26.1M+202.2% -$25.6M-189.9% -$8.8M-1592.6% $591K
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax $11.2M+1306.7% -$929K-143.9% $2.1M-39.8% $3.5M-52.4% $7.4M N/A -$3.6M-132.1% -$1.6M
Net Income $31.2M+840.0% $3.3M-1.6% $3.4M-61.4% $8.7M-38.5% $14.2M+149.6% -$28.6M-237.6% -$8.5M-171.0% -$3.1M
EPS (Diluted) $0.38 N/A $0.04-63.6% $0.11-38.9% $0.18+150.0% $-0.36-227.3% $-0.11-175.0% $-0.04

EYE Balance Sheet

Metric Q1'27 Q4'26 Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25
Total Assets $2.0B+1.9% $2.0B+1.3% $2.0B-0.5% $2.0B-2.1% $2.0B+0.1% $2.0B-0.6% $2.0B-5.9% $2.1B
Current Assets $260.6M+15.5% $225.7M+2.5% $220.2M+1.1% $217.7M-14.3% $254.1M+1.7% $249.8M+2.5% $243.7M-33.1% $364.4M
Cash & Equivalents $67.9M+75.4% $38.7M-30.9% $56.0M+15.6% $48.5M-39.4% $80.0M+8.2% $73.9M-8.9% $81.2M-54.8% $179.5M
Inventory $107.7M+20.6% $89.3M+1.5% $88.0M-1.8% $89.6M+1.2% $88.6M-5.7% $93.9M+7.2% $87.6M-3.7% $91.0M
Accounts Receivable $44.0M-23.3% $57.3M+24.3% $46.1M+0.4% $46.0M-13.6% $53.2M+6.5% $49.9M+6.7% $46.8M-23.4% $61.1M
Goodwill $701.0M0.0% $700.6M0.0% $700.6M+0.3% $698.3M0.0% $698.3M0.0% $698.3M-2.7% $717.5M0.0% $717.5M
Total Liabilities $1.1B+0.7% $1.1B+1.3% $1.1B-1.6% $1.1B-4.8% $1.2B-1.4% $1.2B+1.0% $1.2B-9.4% $1.3B
Current Liabilities $418.5M+1.5% $412.4M-1.1% $417.0M-0.3% $418.2M-10.7% $468.2M0.0% $468.3M+9.9% $426.1M-35.7% $663.2M
Long-Term Debt $220.0M-1.4% $223.2M-2.8% $229.7M-7.3% $247.9M+5.0% $236.1M-1.3% $239.1M-1.3% $242.2M+82.9% $132.4M
Total Equity $898.0M+3.3% $869.5M+1.3% $858.8M+1.0% $850.6M+1.7% $836.2M+2.4% $816.3M-2.8% $840.0M-0.4% $843.4M
Retained Earnings $286.9M+12.2% $255.7M+1.3% $252.4M+1.4% $249.0M+3.6% $240.3M+6.3% $226.1M-11.2% $254.7M-3.2% $263.2M

EYE Cash Flow Statement

Metric Q1'27 Q4'26 Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25
Operating Cash Flow $61.7M+368.9% $13.2M-71.8% $46.6M-14.1% $54.3M+68.3% $32.2M+6.5% $30.3M+8.5% $27.9M-45.7% $51.5M
Capital Expenditures $17.6M-28.0% $24.4M+49.1% $16.4M+38.1% $11.8M-41.4% $20.2M-36.8% $32.0M+34.2% $23.9M+21.7% $19.6M
Free Cash Flow $44.1M+492.7% -$11.2M-137.1% $30.3M-28.6% $42.4M+253.0% $12.0M+791.3% -$1.7M-142.9% $4.1M-87.3% $31.9M
Investing Cash Flow -$18.3M+24.9% -$24.3M-25.6% -$19.4M-52.5% -$12.7M+37.2% -$20.2M+40.0% -$33.7M-38.6% -$24.3M-22.6% -$19.8M
Financing Cash Flow -$14.1M-131.4% -$6.1M+68.9% -$19.7M+73.2% -$73.4M-1258.6% -$5.4M-35.3% -$4.0M+96.1% -$101.9M-4395.4% -$2.3M
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks $10.5M+1518.3% $650K-25.8% $876K+1492.7% $55K-96.6% $1.6M+494.9% $273K+520.5% $44K-18.5% $54K

EYE Financial Ratios

Metric Q1'27 Q4'26 Q3'26 Q2'26 Q1'26 Q4'25 Q3'25 Q2'25
Gross Margin 59.7%+1.6pp 58.1%-0.2pp 58.3%-0.5pp 58.8%-1.0pp 59.8%+2.1pp 57.7%-0.3pp 57.9%+0.8pp 57.1%
Operating Margin 8.3%+7.0pp 1.3%-0.6pp 2.0%-1.4pp 3.4%-1.7pp 5.1%+11.0pp -5.9%-3.9pp -1.9%-2.1pp 0.1%
Net Margin 5.7%+5.1pp 0.7%-0.0pp 0.7%-1.1pp 1.8%-1.0pp 2.8%+9.3pp -6.5%-4.7pp -1.9%-1.2pp -0.7%
Return on Equity 3.5%+3.1pp 0.4%0.0pp 0.4%-0.6pp 1.0%-0.7pp 1.7%+5.2pp -3.5%-2.5pp -1.0%-0.6pp -0.4%
Return on Assets 1.5%+1.4pp 0.2%0.0pp 0.2%-0.3pp 0.4%-0.3pp 0.7%+2.1pp -1.4%-1.0pp -0.4%-0.3pp -0.1%
Current Ratio 0.62+0.1 0.55+0.0 0.530.0 0.52-0.0 0.540.0 0.53-0.0 0.57+0.0 0.55
Debt-to-Equity 0.24-0.0 0.26-0.0 0.27-0.0 0.290.0 0.28-0.0 0.290.0 0.29+0.1 0.16
FCF Margin 8.1%+10.3pp -2.2%-8.4pp 6.2%-2.5pp 8.7%+6.4pp 2.4%+2.8pp -0.4%-1.3pp 0.9%-6.1pp 7.0%

Note: The current ratio is below 1.0 (0.62), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Frequently Asked Questions

National Vision (EYE) reported $2.0B in total revenue for fiscal year 2026. This represents a 9.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

National Vision (EYE) revenue grew by 9% year-over-year, from $1.8B to $2.0B in fiscal year 2026.

Yes, National Vision (EYE) reported a net income of $29.6M in fiscal year 2026, with a net profit margin of 1.5%.

National Vision (EYE) reported diluted earnings per share of $0.37 for fiscal year 2026. This represents a 202.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

National Vision (EYE) had EBITDA of $150.0M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2026, National Vision (EYE) had $67.9M in cash and equivalents against $223.2M in long-term debt.

National Vision (EYE) had a gross margin of 58.8% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

National Vision (EYE) had an operating margin of 3.0% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

National Vision (EYE) had a net profit margin of 1.5% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

National Vision (EYE) has a return on equity of 3.3% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

National Vision (EYE) generated $73.5M in free cash flow during fiscal year 2026. This represents a 92.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

National Vision (EYE) generated $146.3M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

National Vision (EYE) had $2.0B in total assets as of fiscal year 2026, including both current and long-term assets.

National Vision (EYE) invested $72.8M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

Yes, National Vision (EYE) spent $3.2M on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

National Vision (EYE) had 80M shares outstanding as of fiscal year 2026.

National Vision (EYE) had a current ratio of 0.62 as of fiscal year 2026, which is below 1.0, which may suggest potential liquidity concerns.

National Vision (EYE) had a debt-to-equity ratio of 0.24 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

National Vision (EYE) had a return on assets of 1.5% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

National Vision (EYE) has an Altman Z-Score of 2.12, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

National Vision (EYE) has a Piotroski F-Score of 8 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

National Vision (EYE) has an earnings quality ratio of 4.94x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

National Vision (EYE) scores 38 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top